CSIMarket
 


X4 Pharmaceuticals Inc  (NASDAQ: XFOR)
Other Ticker:  
 


X4 Pharmaceuticals Inc's Effective Tax Rate by quarter

Trends, Rankings, Statistics

 



XFOR Effective Tax Rate (Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
Y / Y Pre-Tax Income Change - - - - -
Seq. Pre-Tax Income Change - - - - -
Pre-Tax Income In Millions $0.32 $-39.56 $-36.68 $90.85 $-51.75
Effective Tax Rate 10.76 % - - 0.02 % -
Effective Tax Rate Total Ranking # 259 # # # 6 #
Income taxes expenses / -benefit In Millions $0.03 $0.26 $0.02 $0.02 $0.02
Y / Y Income taxes expenses / -benefit Change 78.95 % - - 350 % -
Seq. Income taxes expenses / -benefit Change -86.82 % - - -5.26 % -


Commenting First Quarter 2025 Effective Tax Rate
Company's effective tax rate in I. Quarter increased compared to the previous quarter to 10.76 %, a new company high.


Looking into I. Quarter results within Biotechnology & Pharmaceuticals industry 3 other companies have achieved lower Effective Tax Rate. While Effective Tax Rate total ranking has deteriorated compared to the previous three months from to 259.

XFOR's Effective Tax Rate first quarter 2025 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 4
Healthcare Sector # 27
Overall # 259

XFOR's Effective Tax Rate Statistics
High Average Low
10.76 % 5.39 % 0.02 %
(Mar 31 2025)   (Jun 30 2024)




Other Effective Tax Rate Profitability Ratios
XFOR's Cumulative Effective Tax Rate
Biotechnology & Pharmaceuticals Industry Effective Tax Rate Trends and Statistics
Healthcare Sector Effective Tax Rate Statistics
Effective Tax Rate Profitability Trends for overall market
XFOR's Effective Tax Rate Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Effective Tax Rate
Lowest Ranking Effective Tax Rate
Effective Tax Rate Profit Margin for XFOR's Competitors
Effective Tax Rate Profit Margin for X4 Pharmaceuticals Inc's Suppliers
Effective Tax Rate Profit Margin for XFOR's Customers

You may also want to know
XFOR's Annual Growth Rates XFOR's Profitability Ratios XFOR's Asset Turnover Ratio XFOR's Dividend Growth
XFOR's Roe XFOR's Valuation Ratios XFOR's Financial Strength Ratios XFOR's Income taxes expenses / -benefit Growth
XFOR's Roa XFOR's Inventory Turnover Ratio XFOR's Growth Rates XFOR's Dividend Comparisons


Companies with similar Effective Tax Rate in the quarter ending Mar 31 2025, within Biotechnology & Pharmaceuticals Industry Effective Tax RateMar 31 2025 MRQ Income taxes expenses / -benefitMar 31 2025 MRQ Pre-Tax Income
Repligen Corp  26.60 %$ 2.113  Millions$ 7.943  Millions
Biogen Inc   22.72 %$ 70.700  Millions$ 311.200  Millions
Gilead Sciences Inc   20.25 %$ 334.000  Millions$ 1,649.000  Millions
Adma Biologics Inc  19.57 %$ 6.546  Millions$ 33.450  Millions
Krystal Biotech Inc   18.04 %$ 7.864  Millions$ 43.597  Millions
Halozyme Therapeutics Inc   17.89 %$ 25.733  Millions$ 143.828  Millions
Immunocore Holdings Plc  17.44 %$ 1.061  Millions$ 6.084  Millions
Exelixis Inc   11.20 %$ 46.074  Millions$ 411.380  Millions
X4 Pharmaceuticals Inc  10.76 %$ 0.034  Millions$ 0.316  Millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com